ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6998
0.00%
Brent Oil
81.965
0.00%
Bitcoin
68,706.00
-0.81%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Marker Therapeutics (delisted) (TPIV)

  7. Marker Therapeutics (delisted) (TPIV) Noticias

TPIV

TapImmune, Inc. (TPIV)

Marker Therapeutics (delisted)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:TPIV
FechaHoraFuenteTítuloSímboloCompañía
19/10/201816:10Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201815:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201815:34Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201815:02Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201815:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201810:45PR Newswire (US)TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And FinancingNASDAQ:TPIVMarker Therapeutics (delisted)
10/10/201805:30PR Newswire (US)TapImmune's HER2/neu-Targeted Breast Cancer Vaccine to be Studied in a Large Phase 2 Immunotherapy Combination Study Funded b...NASDAQ:TPIVMarker Therapeutics (delisted)
25/09/201807:05PR Newswire (US)TapImmune to Present at Two Upcoming Investor ConferencesNASDAQ:TPIVMarker Therapeutics (delisted)
14/09/201813:56Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:TPIVMarker Therapeutics (delisted)
12/09/201807:05PR Newswire (US)TapImmune To Present at 2018 Janney Healthcare ConferenceNASDAQ:TPIVMarker Therapeutics (delisted)
07/09/201816:40Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:TPIVMarker Therapeutics (delisted)
29/08/201805:30PR Newswire (US)TapImmune to Participate at Two Upcoming Industry ConferencesNASDAQ:TPIVMarker Therapeutics (delisted)
09/08/201816:05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TPIVMarker Therapeutics (delisted)
08/08/201815:42Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TPIVMarker Therapeutics (delisted)
13/07/201816:20Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:TPIVMarker Therapeutics (delisted)
21/06/201811:33Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(7) (424b7)NASDAQ:TPIVMarker Therapeutics (delisted)
08/06/201808:15PR Newswire (US)TapImmune Announces Pricing of $70 Million Private PlacementNASDAQ:TPIVMarker Therapeutics (delisted)
31/05/201805:30PR Newswire (US)TapImmune to Present at the Jefferies 2018 Global Healthcare ConferenceNASDAQ:TPIVMarker Therapeutics (delisted)
30/05/201805:30PR Newswire (US)TapImmune to Present at 2018 Sachs Associates Immuno-Oncology BD&L and Investment ForumNASDAQ:TPIVMarker Therapeutics (delisted)
24/05/201815:05Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:TPIVMarker Therapeutics (delisted)
23/05/201805:30PR Newswire (US)TapImmune to Host Investor Webinar on Thursday, May 24th to Discuss Proposed Merger with Marker Therapeutics and Its Transfor...NASDAQ:TPIVMarker Therapeutics (delisted)
22/05/201805:30PR Newswire (US)TapImmune Expands Scientific Advisory Board with Cancer Immunotherapy Pioneers James P. Allison, Ph.D., and Padmanee Sharma, ...NASDAQ:TPIVMarker Therapeutics (delisted)
16/05/201816:15Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TPIVMarker Therapeutics (delisted)
16/05/201805:30PR Newswire (US)TapImmune Creates Scientific Advisory Board to Support Clinical Development of Multi-Antigen Cell Therapy PlatformNASDAQ:TPIVMarker Therapeutics (delisted)
15/05/201815:05PR Newswire (US)TapImmune to Host Investor Breakfast to Discuss Proposed Merger with Marker TherapeuticsNASDAQ:TPIVMarker Therapeutics (delisted)
15/05/201804:32PR Newswire (US)TapImmune and Marker Therapeutics Announce Entry into Merger Agreement, Creating a Transformational Immuno-Oncology PlatformNASDAQ:TPIVMarker Therapeutics (delisted)
07/05/201805:30PR Newswire (US)TapImmune to Present at 2018 NYC Oncology Investor ConferenceNASDAQ:TPIVMarker Therapeutics (delisted)
01/05/201805:30PR Newswire (US)TapImmune to Present at 2018 Disruptive Growth & Healthcare ConferenceNASDAQ:TPIVMarker Therapeutics (delisted)
05/04/201815:05PR Newswire (US)TapImmune Provides Fourth Quarter and Year-End 2017 Corporate and Clinical UpdateNASDAQ:TPIVMarker Therapeutics (delisted)
29/03/201805:30PR Newswire (US)TapImmune to Provide Fourth Quarter and Full Year 2017 Business Update Conference Call and WebcastNASDAQ:TPIVMarker Therapeutics (delisted)
 Showing the most relevant articles for your search:NASDAQ:TPIV

Su Consulta Reciente

FX
USDMXN
US Dollar vs MXN
NASDAQ
AMZN
Amazon.com
CCOM
OILBRENT
Brent Oil
COIN
ETHUSD
Ethereum
NYSE
DIS
Walt Disney
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
AXP
American Express
AMEX
XLE
Energy Select Sector SPDR
AMEX
XLV
Health Care Select Sector
NYSE
MRK
Merck
USOTC
ADDYY
Adidas (QX)
NYSE
XOM
Exxon Mobil
COIN
SOLUSD
Solana
NASDAQ
MSFT
Microsoft
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados